Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
RVL Pharmaceuticals PLC (RVLP) had Income from Continuous Operations of $-51.69M for the most recently reported fiscal year, ending 2022-12-31.
| Income Statement Financials | |
$49.72M |
|
$-51.69M |
|
$9.46M |
|
$40.27M |
|
$108.71M |
|
$-58.99M |
|
$7.28M |
|
$-51.71M |
|
$-51.71M |
|
$-51.69M |
|
|
Income from Continuous Operations |
$-51.69M |
$-51.69M |
|
$-51.69M |
|
$-58.99M |
|
$-42.24M |
|
89.80M |
|
89.80M |
|
$-0.58 |
|
$-0.58 |
|
| Balance Sheet Financials | |
$56.98M |
|
$1.28M |
|
$71.53M |
|
$128.51M |
|
$19.72M |
|
$55.52M |
|
$57.69M |
|
$77.42M |
|
$51.09M |
|
$-18.65M |
|
$51.09M |
|
99.16M |
|
| Cash Flow Statement Financials | |
$-37.81M |
|
$0.13M |
|
$41.78M |
|
$40.44M |
|
$44.54M |
|
$4.10M |
|
$4.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.89 |
|
-- |
|
-- |
|
0.52 |
|
1.11 |
|
80.98% |
|
-118.64% |
|
-118.64% |
|
-84.96% |
|
-104.00% |
|
-103.96% |
|
$-38.56M |
|
-- |
|
-- |
|
-- |
|
0.39 |
|
12.06 |
|
16.40 |
|
22.25 |
|
-101.17% |
|
277.11% |
|
-40.22% |
|
-48.49% |
|
$0.52 |
|
$-0.43 |
|
$-0.42 |
|